Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.

[1]  J. Fay,et al.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. , 2011, Blood.

[2]  E. Shpall,et al.  Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia , 2011, Leukemia & lymphoma.

[3]  Sang Kyu Park,et al.  Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  E. Lanino,et al.  Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party , 2010, Haematologica.

[5]  N. Kröger,et al.  Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review , 2009, Haematologica.

[6]  A. Tichelli,et al.  Recent improvement in outcome of unrelated donor transplantation for aplastic anemia , 2008, Bone Marrow Transplantation.

[7]  J. Klein,et al.  Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. , 2007, Blood.

[8]  G. Socié,et al.  Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. , 2007, Haematologica.

[9]  D. Weisdorf,et al.  Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  R. Collins,et al.  Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. , 2006, Blood.

[11]  F. Locatelli,et al.  Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party , 2005, Bone Marrow Transplantation.

[12]  Y. Lee,et al.  Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia , 2005, Bone Marrow Transplantation.

[13]  Y. Kodera,et al.  Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. , 2002, Blood.

[14]  R. Collins,et al.  Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.